FDA approves Eli Lilly drug for early Alzheimer’s treatment
The US Food and Drug Administration (FDA) has approved a new drug developed by Eli Lilly designed to treat early ...
Read moreDetailsHome / Alzheimer’s
The US Food and Drug Administration (FDA) has approved a new drug developed by Eli Lilly designed to treat early ...
Read moreDetailsThe US Food and Drug Administration (FDA) approved lecanemab, an experimental drug for the treatment of Alzheimer's disease, on Friday. ...
Read moreDetailsA new study in the UK revealed 42 genes having connections with an increased risk of having Alzheimer's. Genetic link ...
Read moreDetailsBreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.
© 2024 · BreezyScroll.com